Safe Abortion: Technical and Policy Guidance for Health Systems

Access to safe abortion is a fundamental component of reproductive health and a critical element of universal health coverage. This page provides an overview of the technical standards and policy recommendations that enable health systems to deliver highquality, personcentred abortion care.

Why Technical and Policy Guidance Matters

In many settings, legal frameworks, service delivery models, and provider competencies are misaligned, leading to unsafe procedures, increased morbidity, and inequitable access. Evidencebased guidance helps health ministries, professional bodies, and NGOs harmonise:

• Clinical protocols with the latest WHO recommendations
• Humanrightsbased policies that guarantee autonomy and dignity
• Supplychain and financing mechanisms that ensure availability of medicines and devices
• Monitoring and accountability systems that track outcomes and equity

Core Technical Components

1. Clinical Service Packages

Safe abortion services should include:

• Counselling and informed consent provide clear, nondirective information about options, procedures, and followup.
• Medical abortion (MA) use of mifepristone+misoprostol (or misoprostol alone where mifepristone is unavailable) up to 12weeks gestation, with evidencebased dosing regimens.
• Surgical abortion vacuum aspiration (manual or electric) for firsttrimester cases; dilation & evacuation (D&E) for second trimester, performed by trained providers.
• Pain management offer NSAIDs, paracetamol, and, where appropriate, opioids, along with nonpharmacological techniques.
• Postabortion care (PAC) treatment of complications, contraception counselling, and psychosocial support.

2. Provider Training and TaskSharing

Evidence shows that midlevel cadres (nurses, midwives, physician assistants) can safely provide MA and manual vacuum aspiration when trained to competence. Key steps:

• Standardised preservice curricula covering anatomy, gestational assessment, medication protocols, infection control, and emergency management.
• Competencybased assessments with direct observation.
• Ongoing mentorship and supportive supervision.
• Clear scopeofpractice regulations that enable tasksharing while protecting patient safety.

3. Supply Chain Management

Reliable access to qualityassured medicines and equipment is essential:

• Forecast demand using service utilisation data.
• Maintain buffer stocks of mifepristone, misoprostol, cannulas, and speculums.
• Implement a push system for remote facilities to avoid stockouts.
• Adopt WHO prequalification and national regulatory approval for all products.

4. Information Systems and Quality Assurance

Data collection should be integrated into routine health information systems:

• Capture procedure type, gestational age, complications, and contraceptive uptake.
• Disaggregate by age, location, and socioeconomic status to monitor equity.
• Use dashboards for realtime stock monitoring and performance feedback.

Policy Guidance

1. Legal Frameworks Aligned with Human Rights

Legislation must:

• Permit abortion on broad health grounds, including social and economic considerations.
• Remove criminal penalties for persons seeking lawful care and for providers acting within the legal scope.
• Guarantee confidentiality and nondiscrimination.

2. Financing Strategies

To achieve universal coverage, governments should:

• Include abortion services in national health benefit packages.
• Allocate dedicated budgets for MA medicines and training.
• Explore resultsbased financing that rewards reduction in unsafe abortion rates.

3. Service Delivery Integration

Abortion care should be embedded in existing reproductive health platforms:

• Primary health centres, outreaches, and communitybased distribution of MA where legally permissible.
• Integration with family planning, maternalchild health, and HIV services to promote comprehensive care.

4. Community Engagement and Stigma Reduction

Effective policies support demandside interventions:

• Public awareness campaigns that clarify legal rights and dispel myths.
• Engagement with civil society, youth groups, and religious leaders to foster supportive environments.

Implementation Checklist

• Review national law and amend restrictive provisions.
• Adopt WHOendorsed clinical guidelines and adapt them to local contexts.
• Develop a national training plan for providers, including tasksharing components.
• Secure procurement contracts for mifepristone and misoprostol.
• Integrate abortion indicators into the health management information system.
• Allocate financing within the universal health coverage scheme.
• Launch a stigmareduction communication strategy.

Further Resources

• World Health Organization, Safe Abortion: Technical and Policy Guidance for Health Systems
• Guttmacher Institute, Research on Abortion Access
• UNFPA, Sexual and Reproductive Health Toolkit